| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |